Navigation Links
Dairy Veterinarians Highlight Need for Improved Methods for Detecting Mastitis
Date:10/29/2008

Ability to detect mastitis at subclinical level and in early lactation

would benefit producers

RESEARCH TRIANGLE PARK, N.C., Oct. 29 /PRNewswire/ -- Current methods for detecting and diagnosing mastitis in dairy cows are not serving the needs of dairy producers well, according to a survey of leading dairy veterinarians conducted at the recent annual meeting of the American Association of Bovine Practitioners in Charlotte, NC. The veterinarians surveyed are responsible for nearly 2 million cows in the United States.

Survey respondents rated current detection methods only an average of 5.2 on a 10-point scale for their ability to meet producers' needs. In addition, veterinarians overwhelming supported the importance of detecting mastitis at the subclinical level and in early lactation period for freshened cows. Mastitis, an infection in milk-producing glands in dairy cows, results in a $2 billion loss in the $25 billion U.S. milk production industry each year.

"The survey results highlight the need for earlier, quicker and more accurate detection of mastitis," said Rudy Rodriguez, president and chief technology officer, Advanced Animal Diagnostics (AAD). "Technology developed by AAD will allow simple and accurate analysis of differential inflammatory cell counts in addition to the traditional somatic cell count to diagnose mastitis."

Introduced in the 1960s, somatic cell count method measures the total number of leukocytes (white blood cells) in a milk sample. Proprietary AAD technology allows the detection of three different types of leukocytes -- lymphocytes, neutrophils and macrophages -- which provides the ability to detect mastitis at a subclinical level, much earlier than by measuring somatic cell counts.

Of survey respondents, 94 percent said that differential counts are more effective than traditional measures of detecting mastitis. In addition, veterinarians rated the importance of detecting mastitis at a subclinical level at an 8.7 on a 10-point scale.

"The bottom line is delivering an easy-to-use technology that will help dairy producers increase profits by detecting and treating mastitis at an earlier, subclinical level," said Rodriguez. "Producers will be able to treat infected cows earlier, reducing loss of milk production and risk of infection to other cows in the herd."

Veterinarians overwhelmingly stated that it is important to detect mastitis at freshening, rating it at 8.9 on a 10-point scale. Incidence of mastitis is highest shortly after calving, with 35 percent of all infections starting in early lactation. Current methods do not allow practical testing of all cows following calving, however measurement of differential inflammatory cell counts with new technology from AAD allows detection of mastitis in colostrum at the quarter level.

Advanced Animal Diagnostics (AAD) was founded in 2001 to commercialize exclusively licensed proprietary technology for the diagnosis of valuable-farm-animal diseases, beginning with those that affect milk and milk products. In addition, the company has also developed intellectual property internally, which, with the first platform will have many applications in farms and veterinary medicine. AAD is located at 1912 HWY 54 East, Durham, NC 27713. For more information about Advanced Animal Diagnostics, please visit http://www.advancedanimaldiagnostics.com.


'/>"/>
SOURCE Advanced Animal Diagnostics (AAD)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns
2. PA Agriculture Department Warns Consumers About Raw Milk Sold by York County Dairy
3. National Dairy Council Joins USDA in Partnering With MyPyramid
4. ExploreDairy.com Debuts With Information on Minnesota Dairy Events, People and Products
5. Wildcat Power Cord Repairs Cruciate Ligament in Dairy Cows Knee
6. African Americans at Risk for Low Calcium Intake - New Survey Finds Those Experiencing Symptoms of Lactose Intolerance May be Sidelining Dairy in Their Diets
7. Allergy Alert on Undeclared Soy Ingredient in Bulk Cases of GFS Ultra-Pasteurized Non-Dairy Creamer
8. Low-Fat Dairy Reduces High Blood Pressure Risk
9. IDFA: Dairy Processors Urge Further Review of Cloning
10. PA Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Perry County Dairy
11. Post-Graduate Veterinary Education - Residencies and Internships - Becoming Very Popular Among New Veterinarians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... insurance management and financial planning assistance to clients in southern Montana, is announcing ... offered by Zoo Montana. , The outreach programs offered by Zoo Montana provide ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... the appointment of Mike Finnegan to the position of Executive Vice President, Sales ... experience in healthcare technology, telehealth and medical device sales leadership. He has received ...
(Date:6/27/2017)... Philadelphia PA and London UK (PRWEB) , ... June 27, 2017 ... ... for applying to a clinical study is whether they can trust the sponsor to ... competitive, it is vital that sponsors and CROs establish payment strategies that encourage sites ...
(Date:6/27/2017)... Orlando, FL (PRWEB) , ... June 27, 2017 ... ... the leading payment solution for many of the health care industry’s hospitals and ... its new patient financing portal for select customers. Parasail Health is a San ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/9/2017)... Calif. , June 9, 2017 AirXpanders, ... company focused on the design, manufacture, sale and distribution ... market on the progress of its commercial roll-out in ... now available in more than one hundred (100) medical ... AeroForm offers a needle-free alternative for women ...
Breaking Medicine Technology: